Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/28/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/25/20 | Current report filing |
|
5 | ||
| 08/10/20 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
53 | |
| 08/06/20 | Current report filing |
|
9 | ||
| 07/29/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/17/20 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
38 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/09/20 | Statement of changes in beneficial ownership of securities |
|
1 |